Ultrasonic vein mapping prior to infrainguinal autogenous bypass grafting reduces postoperative infections and readmissions  by Linni, Klaus et al.
From the Society for Vascular Surgery
Ultrasonic vein mapping prior to infrainguinal
autogenous bypass grafting reduces postoperative
infections and readmissions
Klaus Linni, MD,a Nina Mader, MD,a Manuela Aspalter, MD,a Enzo Butturini, MD,a
Ara Ugurluoglu, MD,a Wolfgang Hitzl, MSc, PhD,b and Thomas J. Hölzenbein, MD, PhD,a Salzburg,
Austria
Objective: Although duplex vein mapping (DVM) of the great saphenous vein (GSV) is common practice, there is no level
I evidence for its application. Our prospective randomized trial studied the effect of preoperative DVM in infrainguinal
bypass surgery.
Methods: Consecutive patients undergoing primary bypass grafting were prospectively randomized for DVM of the GSV
(group A) or no DMV of the GSV (group B) before surgery. Society for Vascular Surgery reporting standards were
applied.
Results: From December 2009 to December 2010, 103 patients were enrolled: 51 (group A) underwent DVM of the GSV,
and 52 (group B) did not. Group A and group B not differ statistically in age (72.8 vs 71.1 years), sex (women, 29.4%
vs 34.6%), cardiovascular risk factors, body mass index (25.9 vs 26.1 kg/m2), bypass anatomy, and runoff. Group A and
B had equal operative time (151.4 vs 151.1 minutes), incisional length (39.4 vs 39.9 cm), and secondary bypass patency
at 30 days (96.1% vs 96.2%; P .49). Conduit issues resulted in six intraoperative changes of the operative plan in group
B vs none in group A (P .014). Median postoperative length of stay was comparable in both groups (P .18). Surgical
site infections (SSIs) were classified (in group A vs B) as minor (23.5% vs 23.1%; P  1.0) and major (1.9% vs 21.2%;
P .004). Readmissions due to SSIs were 3.9% in group A vs 19.2% in group B (P .028). Two patients in group B died
after complications of SSIs. Multivariate analysis identified preoperative DVM as the only significant factor influencing
the development of major SSI (P  .0038).
Conclusions: Routine DVM should be recommended for infrainguinal bypass surgery. The study found that preoperative
DVM significantly avoids unnecessary surgical exploration, development of major SSI, and reduces frequency of
readmissions for SSI treatment. (J Vasc Surg 2012;56:126-33.)
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tReports on preoperative duplex vein mapping (DVM)
in patients undergoing infrainguinal bypass surgery date
back to the early times of vascular ultrasound examinations.
Preoperative knowledge about vein anatomy and its suit-
ability for bypass grafting were the main incentives to use
vein mapping.1,2 Further studies suggested that DVMmay
ease harvest of the great saphenous vein (GSV) and there-
fore may be able to reduce the risk of postoperative surgical
site infections (SSIs).3-8 SSIs in vascular surgery are re-
ported in up to 43% and may lead to increased length of
hospital stay (LOS) and costs generated thereby.9,10
To date, there is no prospective randomized study
available investigating the role of DVMbefore infrainguinal
bypass surgery. Previous reports investigating DVM fail
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126evel I evidence. The aim of our prospective randomized
rial was to assess the effect of preoperative DVM on the
onduct of infrainguinal bypass surgery, the outcome of the
atients, and to prove if preoperative DVM prevents post-
perative SSI significantly.
ETHODS
During a 1-year period, all patients admitted for in-
rainguinal bypass surgery at a tertiary care university-based
enter were evaluated for inclusion in this study. Patients
articipating in the study provided written informed con-
ent and were randomly assigned to two groups: group A
eceived preoperative DVM of the ipsilateral GSV and
roup B did not. Study inclusion criteria were severe clau-
ication (walking distance 20 meters) and critical leg
schemia present for 2 weeks, according to the Fontaine
lassification,11 popliteal aneurysm, and present ipsilateral
SV in patients undergoing primary bypass surgery. Exclu-
ion criteria were acute leg ischemia, redo bypass proce-
ures, trauma cases, combined procedures (bypass with
ransluminal angioplasty or other bypass procedures, eg,
liac-femoral bypass), or absent GSV because of previous
ein stripping, peripheral bypass, or coronary artery bypass.
SSIs were classified as superficial or deep according to
he American College of Surgeon’s National Surgical Qual-
ty Improvement Program (ACS-NSQIP).12 SSIs were re-
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Volume 56, Number 1 Linni et al 127garded as minor when oral antibiotics and topical treatment
were sufficient or major when intravenous antibiotic ther-
apy or redo surgery, or both, was required. Samples for
bacterial culture were taken from ischemic or gangrenous
lesions of the leg and from areas of the SSI.
Primary study end points were duration of the opera-
tive procedure, incisional length, change of operative plan,
and the development of postoperative SSI, the severity of
SSI, and its treatment duration. Secondary end points were
bypass patency, limb salvage, and patient survival. Society
for Vascular Surgery reporting standards were applied.13
The study was approved by the Local Ethics Research
Committee. Patient data were recorded prospectively in a
designated vascular database.
Preoperative DVM, angiography, and distal runoff.
Preoperative color-flow duplex ultrasound (DUS) scanning
of the GSV was done in the vascular laboratory with a
13-MHz probe (GE Healthcare LOGIQ 7, Milwaukee,
Wisc) with the patient supine. The diameter of the vein was
measured at the proximal thigh and distal calf using a
high-thigh tourniquet.14 The course of the vein from me-
dial malleolus to the groin was marked with a waterproof
pen. Intraluminal echoes as signs of phlebitis or thrombo-
sis, venous compressibility as a sign of patency, valves,
sclerosis, and tributaries of the GSV were recorded and
marked on the skin. The GSV was regarded as usable for
bypass if the diameter was 2.5 mm and there were no
signs of thrombosis or sclerosis. DVM was performed by
three senior surgeons (K.L., E.B., and A.U.).
Preoperative angiography was performed as digital sub-
traction angiography (DSA) with puncture of the common
femoral artery (CFA) of the affected limb in all patients.
Distal arterial runoff was scored according to patent tibial
arteries evaluated by preoperative DSA.13
Antibiotic and antithrombotic regimen. Patients
without ischemic ulceration or gangrene received antibiotic
prophylaxis with intravenous cefazolin (2 grams) at induc-
tion and at 8 and 16 hours postoperatively. Patients with
ischemic ulceration or gangrene received continuous antibi-
otic therapy from the day of admission. Oral anticoagulation
and antiplatelet therapy were replaced by low-molecular-
weight heparin at least 3 days before bypass surgery.
Surgical procedures. The procedures were performed
by four senior surgeons (K.L., N.M., E.B., and T.H.) and
one fellow (M.A.) supervised by a senior surgeon.
Vein harvest and intraoperative vein measurement.
In cases of nonreversed and reversed bypasses, ipsilateral
GSV was harvested by using multiple vertical skin incisions
with intervening cutaneous bridges after dissection of in-
flow and outflow arteries. Incisions were performed with a
scalpel, and cautery was used for hemostasis in the deeper
layers. The vein was gently flushed, and the proximal valves
were excised under direct vision. The remaining valves were
lysed by a Mill’s type valvulotome introduced through the
distal end of the vein.
In cases of in situ grafts, the GSV was exposed by
multiple vertical skin incisions (in cases of preoperative
duplex at the sites of venous side branches), and a flexible palvulotome (UreSil Tru-Incise, Skokie, Ill) was used for
ysis of valves. Intraoperative measurement of graft diame-
er and length was performed using a caliper and a ruler in
ll types of bypasses. Incisions were closed with running
ingle-layer subcuticular sutures using 3-0 Vicryl (Ethicon,
omerville, NJ) and stainless skin staples in all types of
ypasses.
The technique used for bypass surgery was at the dis-
retion of the surgeon. Technical details of nonreversed,
eversed, and in situ bypass procedures that were performed
n this study have been reported previously.15-17
Postoperative follow-up. Routine postoperative clinical
xaminations were at 1, 3, 6, and 12months. The surveillance
rogram included measurement of ankle-brachial pressure
ndex (ABPI) and DUS scans of the bypass. Patients with SSI
ere seen more frequently.
Statistical methods. Data are presented as mean 
tandard deviation, medians with range, and percentages,
espectively. Cross-tabulation tables, together with Fisher
xact test and Pearson 2 test, were used to analyze the
ercentages between discrete variables. Two-sided, un-
aired Student t-tests were used to compare continuously
istributed data, which were metrically scaled and approx-
mately normally distributed. Kaplan-Meier curves with
5% confidence intervals (CIs) were computed and com-
ared using the log-rank test and Cox F test. All analyses
ere done with Statistica 6.1 software (StatSoft Inc, Tulsa,
kla). A value of P .05 indicated a statistically significant
esult.
ESULTS
Patients. From December 2009 to December 2010,
54 patients were admitted for infrainguinal bypass sur-
ery, and 107 (69.5%) were eligible for the study, four
3.7%) of which refused randomization. Of the 103 ran-
omized patients, 51 (49.5%) were allocated to group A
with DVM) and 52 (50.5%) to group B (without DVM;
ig). The groups did not differ statistically in demographic
ata, risk factors, body mass index (BMI), indication for
urgery, runoff anatomy, and bypass length (Table I).
Distal run-off and preoperative ABPI. Preoperative
ngiography revealed an average of 1.4 0.7 runoff vessels
n group A patients and 1.7 0.8 in group B (P .1). The
ean preoperative ABPI was 0.64  0.26 in group A and
.62  0.36 in group B (P  .75).
Preoperative and intraoperative findings of ipsilat-
ral GSV. The mean diameters of preoperatively mapped
SVs in 51 group A patients were 4.9 2.17mm proximal
high, 4.5  1.61 mm distal thigh, 3.2  0.92 mm proxi-
al calf, and 3.4  1.15 mm distal calf. All mapped veins
ere patent and showed segments suitable for the intended
ypass graft. The intraoperative measurements of the vein
raft were equal between group A and group B: 5.5 2.05
s 5.3  2.4 mm at the proximal thigh (P  .62), 5.1 
.53 vs 5.0  2.0 mm at the distal thigh (P  .7), 3.8 
.03 vs 3.5  1.6 mm at the proximal calf (P  .33), and
.9 1.22 vs 3.7 1.6mm at the distal calf (P .39). The
reoperatively and intraoperatively measured vein diame-
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levels).
Surgical procedures. Most of the bypass procedures
Fig. Patient randomization and exclusion for the stud
Table I. Demographic data, risk factors, and indication
for operation in 103 randomized patients with (group A)
and without (group B) duplex vein mapping
Variablesa
Group A
(n  51)
Group B
(n  52) P
Average age, years
(range) 72.8 (51.9-93.8) 71.1 (55.9–90.8) .39
Female 15 (29.4) 18 (34.6) .67
BMI, kg/m2
(range) 25.9 (19.3–43.3) 26.1 (19.8–40.8) .76
Hypertension 40 (78.4) 44 (84.6) .46
Cholesterol 25 (49.0) 26 (50.0) .99
Diabetes 24 (47.0) 22 (42.3) .99
Smoking 23 (45.0) 24 (46.2) .99
Coronary artery
disease 18 (35.3) 19 (36.5) .99
Renal impairmentb 16 (31.4) 14 (26.9) .67
Previous
intervention
Vascular
operation 7 (13.7) 6 (11.5) .77
CABG/coronary
stent 5 (9.8) 6 (11.5) .99
Rest pain 6 (11.8) 10 (19.2) .42
Ulceration/gangrene 35 (68.6 31 (59.6) .42
Popliteal aneurysm 3 (5.9) 7 (13.5) .31
BMI, Body mass index; CABG, coronary artery bypass grafting.
aContinuous data are presented as average and categoric data are presented
as number (%).
bDefined as serum creatinine1.5 mg/dL or glomerular filtration rate45
mL/min/m2.performed were femoral-infrapopliteal bypasses to tibial mnd pedal target vessels. This was similar in both groups
Table II). Translocated nonreversed bypass was the pre-
erred surgical technique, followed by reversed bypass and
n situ GSV. The study groups did not differ significantly in
perative time, incisional length, intraoperatively evaluated
enous diameter, and overall bypass length (Table II).
ntraoperative changes of surgical strategy. The intra-
perative surgical strategy was changed in 6 of 51 patients
11.7%, Table II) in group B vs none in group A (P 
014). This change was always due to venous conduit
ssues. The GSV diameter was insufficient in four patients,
nd the GSV was partially thrombosed in two. Bailout
rocedures were autogenous infrainguinal bypasses using
he accessory saphenous vein (n  3) with an alternative
nflow or the short saphenous vein (n  2; Table III). A
ridge graft18 was constructed in one patient with a short
sable segment of the GSV. In these patients, the mean
ength of incision was 66 cm (Table III), which was statis-
ically longer than in the remainder of group B patients
95% CI, 36.1-44.6; P  .0001) and group B patients
verall (95%CI, 37.1-42.6; P .0001). Operative time did
ot differ in these groups.
Postoperative LOS and anticoagulation. The me-
ian postoperative LOS was 10 days (range, 5-31 days) in
roup A vs 11.5 days (range, 4-29 days) in group B (P 
18). Postoperative oral anticoagulation was administered
o 11 of 51 group A patients (21.5%) and to 17 of 52 group
patients (32.7%), most often because of atrial fibrillation
P  .27).
Postoperative SSI and readmissions. Of the 103
andomized patients, 42 SSIs were observed in 36 patients
34.9%): 14 of 42 (33%) in group A and 28 of 42 (67%) in
roup B. Readmissions due to SSIs occurred significantly
M, Duplex vein mapping; GSV, great saphenous vein.ore often in group B patients (odds ratio [OR], 5.8; 95%
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Volume 56, Number 1 Linni et al 129CI, 1.2-28.1; P  .016). Median duration of LOS at
readmission was 7 days (range, 4-10 days) in group A vs 8.5
days (range, 6-23 days) in group B (P  .42). This differ-
ence was not significant, indicating a similar severity of SSI
in both groups (Table IV).
SSI and proximal/distal bypass anastomosis. Of 42
Table II. Surgical procedures and intraoperative findings
(group B) duplex vein mapping
Procedurea
Group A
(n  51)
Bypass type
Femoral-popliteal 14 (27.5
Femoral-infrapopliteal 37 (72.5
Nonreversed 40 (78.4
Reversed 7 (13.7
In situ 4 (7.8)
Bridge graft 0 (0)
Operative time, min 151.4  49
Incisional length, cm 39.4  12
Bypass length, cm 33.9  9.
Operative plan changed 0 (0)
aContinuous data are presented as average and categoric data are presented
Table III. Change of operative management in six patient
conduit
Pt
Operative
time (min)
Incisional
length
(cm) GSV
1 143 73 Occluded
2 139 80 Sclerotic
3 203 66 Occluded
4 204 45 Sclerotic
5 87 80 Short
6 135 52 Occluded
All 152  40.9b 66  13.4b
ASV, Accessory saphenous vein harvest; BG, bridge graft; GSV, great saphen
aDied of septic complications after major surgical site infection and bypass b
bMean  standard deviation.
Table IV. Postoperative surgical site infections,
readmissions, and deaths in 103 randomized patients with
(group A) and without (group B) duplex vein mapping
Outcomea
Group A
(n  51)
Group B
(n  52) P
SSI
Minor 12 (23.5) 12 (23.1) .99
Major 1 (1.9) 11 (21.2) .004
Readmissions due to SSI 2 (3.9) 10 (19.2) .028
LOS per readmission,
days 7 (4-10) 8.5 (6-23) .42
Deaths due to SSI 0 2 .49
SSI, Surgical site infection.
aCategoric data are presented as number (%) and continuous data as median
(range).SSIs, 14 (33.3%) were (in group A vs group B) at the site of wxposure for the proximal anastomosis (3 vs 11; P .041),
(21.4%) were at the site of exposure for the distal anasto-
osis (3 vs 6; P  .31), and 19 (45.2%) were at the site of
ein harvest (8 vs 11; P  .73).
Minor SSIs. Minor SSIs occurred in 23% of patients in
oth groups, without significant difference (Table IV). The
ites of minor wound complications in group A were the
roin in five, distal thigh in four, proximal thigh in two,
roximal calf in one, and distal calf in one. Minor SSIs in
roup B were in the groin in one, at the proximal thigh in
ne, middle thigh in two, distal thigh in two, proximal calf
n three, and middle calf in four. One group A patient with
minor SSI of the distal thigh was readmitted for 4 days for
ound care because of inadequate attendance at home.
Major SSIs. There was a significant difference be-
ween group A and B patients in major SSIs (P  .004).
he corresponding OR was 13.4 (95% CI, 1.7-108; P 
0025) (Table IV). One (1.9%) adipose man (BMI, 41.2
g/m2) in group A with severe claudication and consecu-
ive femoral-infrapopliteal bypass surgery (operative time,
10 minutes; incisional length, 50 cm) was readmitted 14
ays after primary surgery due to a major SSI at the distal
high. Redo surgery with debridement of necrotic tissue
3 randomized patients with (group A) and without
Group B
(n  52) P
11 (21.2) .49
41 (78.8) .49
39 (75.0) .82
11 (21.2) .44
1 (1.9) .20
1 (1.9) 1.0
151.1  55.4 1.0
39.9  14.3 .74
33.0  8.71 .61
6 (3.1) .014
ber (%).
group B due to the lack of information about the venous
SSI
Complicationsilout Major Minor
SV No No . . .
SV Yes No Died after readmissiona
SV Yes No Graft occlusion
SV No Yes Graft occlusion
G Yes No . . .
SV No Yes . . .
3 2 . . .
ein; SSI, surgical site infection; SSV, short saphenous vein harvest.
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with a mean BMI of 26.8 3.9 kg/m2. The sites of wound
complications were the groin in five, distal thigh in five,
middle thigh in two, the proximal calf in one, the middle
calf in one, and the distal calf in one. Mean operative time
for primary bypass surgery and mean length of surgical
incisions were 168.8 64.6 minutes and 44.7 20.0 cm,
respectively, which did not differ compared with the overall
group (P  .28 and P  .24, respectively).
Of 11 group B patients, 10 (91%) required readmission
for redo surgery (n  5) or intravenous antibiotic therapy
(n 5) due to amajor SSI. Onemanwith amajor SSI at the
distal thigh refused readmission. He was managed conser-
vatively for 4 months until his wound complication was
healed. The mean LOSs preoperatively, postoperatively,
and at readmission were 5.8 2.6, 12.6 5.9, and 10.6
5.5 days, respectively. Two patients in group B (3.8%) with
severe SSIs died. Both presentedwith cardiac failure after redo
surgery. One woman sustained bleeding from femoral-
infrapopliteal bypass due to a SSI at the middle thigh. The
bypass was saved, but she died 7 days later of septic com-
plications with consecutive cardiopulmonary insufficiency.
One man with methicillin-resistant Staphylococcus aureus
infection of the distal thigh underwent reoperation with
debridement of necrotic tissue but died of cardiac failure 10
days later.
Multivariate analysis. Multivariate analysis identified
preoperative DVM as the only significant factor in prevent-
ing the development of postoperative major SSI (P 
.0038; Table V).
Bypass patency. Seven bypasses (6.8%) occluded. Two
bypass in each group failed 30 days. The 30-day secondary
bypass patency rates were 96.1% for group A vs 96.2% for
group B (Cox F test; P  .49). Late bypass occlusions were
observed in one group A patient at 6 weeks and in two group
B patients at 9 and 10 weeks, respectively. The cause for early
Table V. Factors influencing the development of major
surgical site infection (multivariate analysis)
Factors P
Female sex .19
Bypass type
Femoral-popliteal .99
Femoral-infrapopliteal 1.0
Nonreversed .29
Distal run-off .43
Diabetes .99
Hypertension .69
Body mass index .24
Cholesterol .99
Smoking .99
Renal impairment .74
Coronary artery disease .11
Fontaine IV (tissue loss)11 .28
Anticoagulation .08
Pre-op duplex vein mapping .0038and late bypass occlusions could not be determined. pOutcome of six group B patients with intraopera-
ive change of surgical strategy. There was a significant
ncrease of overall postoperative SSIs (5 vs 31; OR, 10.6;
5% CI, 1.2-95; P  .011) and of major SSIs (3 vs 9; OR,
.8; 95% CI, 1.7-55.8; P  .0027), respectively, between
atients with and without intraoperative change of surgical
trategy. There was no significant difference in minor SSIs
2 vs 22; P .62), bypass occlusions (2 vs 5; P .052), and
eaths (1 vs 1; P .11), respectively, between patients with
nd without intraoperative change of surgical strategy (Ta-
le III).
Follow-up, limb salvage, and survival. No patient
as lost to follow-up. Mean follow-up was 8.7 months
range, 2.8-14.5 months) for group A and 8.3 months
range, 1.2-15 months) for group B (P  .61). Six minor
mputations in group A and five in group Bwere performed
uring the follow-up period. One diabetic patient in group
without an SSI and with patent bypass graft underwent
elow-knee major amputation 6 months after bypass sur-
ery because of progressive gangrene of the foot, yielding a
imb salvage rate of 98% in group B. Survival rates were
00% in group A and 96% in group B.
ISCUSSION
To our knowledge, this is the first prospective random-
zed trial investigating the effect of preoperative DVM of
he ipsilateral GSV on the outcome of patients undergoing
nfrainguinal bypass surgery. It revealed that patients with-
ut preoperative mapping were more prone to major post-
perative SSIs and consecutive readmissions than patients
ndergoing preoperative DVM. We observed that intraop-
rative change of surgical strategy due to venous conduit
ssues was significantly more common in patients without
reoperative DVM and that their outcomes were less favor-
ble.
Multivariate analysis identified preoperative DVM of
he ipsilateral GSV as the only significant factor influencing
evelopment of major SSIs (P  .0038) after infrainguinal
ypass surgery. The study investigated preoperative DVM
n nonreversed, reversed, and in situ infrainguinal bypasses.
ost of the previous studies only reported on the effect of
VM before in situ bypass grafting.3-5,7,19-21
A major advantage of preoperative DVM is that mor-
hologic and anatomic characteristics of the vein can be
ssessed accurately. In cases of in situ bypass grafts, venous
ributaries can be detected and marked by preoperative
US imaging, which minimizes venous exposure and de-
reases the risk for wound complications.3,20 Four patients
ith preoperative DVM underwent in situ bypass proce-
ures. In all cases, side branches were detected sufficiently
y preoperative DUS and could be ligated through small
kin incisions, leaving no arteriovenous fistulas at comple-
ion angiography. None of these patients suffered major
SIs.
DVM enables preoperative assessment of suitability
patency, diameter, and length) of the ipsilateral GSV for
onsecutive infrainguinal bypass grafting. In six group B
atients (without DVM), the surgical strategy had to be
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GSV patency or length (Table III). Therefore, they all
required bailout procedures that might have been avoided
had reoperative DVM been done. Postoperative SSIs de-
veloped in most of these patients, which was statistically
significant compared with patients without intraoperative
change of surgical strategy, and the outcome was less
favorable (two bypass occlusions and one death due to
septic complications).
We believe the most essential part of preoperative
DVM is accurate skin marking of the course of the vein.
The surgeon is thus able to plan the incisions more precisely
without creating skin flaps and therefore minimizes the risk
for a major SSI.
It was surprising that there was no significant difference
between our study groups in operative time and incisional
length, which led us to conclude that preoperative DVM
and marking does not speed up the procedure. Similar
results were reported by Maini et al in 1993.20
How to perform skin incisions to avoid wound compli-
cations is controversial: some authors favor parallel groin
incisions for arterial and venous exposure to keep lymphatic
vessels intact, whereas others prefer vertical incisions be-
cause adequate exposure of the saphenous vein and femoral
artery, especially in patients undergoing in situ bypass graft-
ing, could be limited by an oblique or parallel dissection of
the groin and proximal thigh.20,22 In this study, vertical
skin incisions with intervening cutaneous bridges for arte-
rial and venous exposure were performed.
The most common sites of major and minor SSIs in our
trial have been the groin and the distal thigh, which are
known as vulnerable sites for infections because of an
extensive lymphatic network. Although major SSIs devel-
oped in 11.7% of our patients, an overall SSI rate of 36%was
high, which raises the question of whether oblique skin
incisions, especially in the groin and distal thigh, could have
prevented some SSIs reported in our study.
Endoscopic vein harvesting has the theoretic advantage
of reduced wound complications because fewer skin inci-
sions are required. Yet, the operative trauma through ex-
tensive undermining of the skin in an ischemic leg is sub-
stantial, and no reduction of wound complications or LOS
has been reported.23
The study revealed a significant increase in overall SSIs
at the site of exposure for the proximal anastomosis in
group B patients (P  .041). We believe this difference is
not correlated with the use of preoperative DVM, because
most of the proximal anastomoses were performed in the
groin, where preoperative DVM does not play a major role
in preventing SSI.
Some authors argue that deeper positioned (eg, subfas-
cial) venous bypass grafts are less prone to SSI and are more
safe in cases of superficial SSIs compared with subcutane-
ously running grafts.24 We believe that the technique of
positioning all bypass grafts subcutaneously reduces the
tendency to stricture development and has the advantage
that the graft can be easily palpated by the physician and
self-controlled by the patient. However, one patient sus-ained bypass bleeding caused by a major SSI of the distal
high and later died of septic complications, which could
ave been prevented if the graft had been positioned sub-
ascially.
Previous studies reported a number of other parame-
ers, such as female sex,25 anticoagulation,25 obesity,26
iabetes,27 and older age,28 predicting the development of
SIs after infrainguinal bypass surgery. In the study, these
arameters were equally distributed between the study
roups and were not predictive of postoperative SSIs.
ONCLUSIONS
Preoperative DVM in patients undergoing infraingui-
al bypass surgery does not speed up surgery, shorten
ncisions, avoid technical errors, or improve bypass patency.
owever, preoperative DVM and marking of the ipsilateral
SV does avoid unnecessary surgical exploration and an
ntraoperative change of surgical strategy, which leads to a
ignificant reduction of postoperative major SSIs and con-
ecutive readmissions. The method should become stan-
ard technique in the preoperative diagnostic setting of
atients undergoing infrainguinal bypass grafting, and fur-
her studies investigating the cost-effectiveness of preoper-
tive DVM should be performed.
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Dr Peter Lawrence (Los Angeles, Calif). Could you tell us
more in detail about techniques that you used to avoid infection?
Did you avoid parallel incisions or transpose the vein in certain
cases to avoid below-calf incisions? What other techniques do you
use in addition to identifying the vein?
Dr Klaus Linni. First of all, it is very important to follow the
course of the vein exactly, because the problems are mainly caused
by the creation of skin flaps, so it is important to mark the vein as
accurately as possible. Concerning the type of incisions, we pre-
ferred vertical incisions with intervening cutaneous bridges in all
types of bypasses. On the other hand, some of the surgical site
infections (SSIs) in our patients were at the groin and distal thigh,
which could have been avoided by parallel incisions. We usually do
not perform transpositions of the vein to avoid below-knee or
below-calf incisions.
Dr Alan Dardik (New Haven, Conn). How far in advance do
you do the marking? Do you do it the morning of or the day
before?
Dr Linni. Day before, usually.
Dr Dardik. And then when you make your incision, do you
make your incision through the mark or do you avoid the mark?
Dr Linni. We perform the vein marking the day before the
procedure.
Dr Dardik. So do you believe, perhaps, the composition of
your dye, if it has an alcohol base or some thing else, may be an
antibiotic effect?
Dr Linni. Maybe. It is a very interesting question. We haven’tDr Jeffrey Kaufman (Springfield, Mass). A couple of ques-
ions about your technique that would influence your outcomes.
o you use bridged incisions ever?
Dr Linni. Yes, we did it in all cases.
Dr Kaufman. Do you tend to put the vein back in its bed, or
re you running it anatomically parallel to the artery?
Dr Linni. All of our bypasses are running subcutaneously but
ot in the original vein bed.
Dr Kaufman. Did you look at the error rate in terms of the
apping?My subjective impression has been that the technologists
on’t always get it right, about 10% of the time, and it has been a
outine in my practice, since about 1984, to check these myself. It
akes only a few minutes. By the way, you can apply the same
echniques to trauma. By the time the anesthesiologist is finished
orking on the patient you have your mapping. So have you
hecked the mapping yourself?
Dr Linni. We did not especially check the error rate concern-
ng the accurateness of the preoperative marking. But our experi-
nce is that in the beginning there was a kind of parallax error
roblem, which improved after a certain time. And you are right,
ith increasing experience the time used for duplex vein mapping
DVM) gets shorter.
Dr Kaufman. The reason I think people need to check it
hemselves is that the technologists don’t always position the leg
roperly in a mode that mimics what you do during the case, and
o there is a parallax error problem that can cause you to put the
ncision in the wrong spot.Dr Linni. You are absolutely right, but we perform the
apping ourselves without the help of a technologist.
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United States we have a problemwith higher weight in our patients
than you probably have in Austria and that would lead to parallax
error. Have you had that problem?
Dr Linni. The body mass index was similar in both groups.
And you are right, our patients seem to have less of a weight
problem than yours.
Dr Munier Nazzal (Toledo, Ohio). You mentioned that there
was no difference between both groups when it comes to surgical
time. How do you explain that there was no difference in the surgical
time between both cases although you were searching for a vein?
Dr Linni. Same time in both groups, indeed.
Dr Nazzal. Well, how do you explain that if you spent time
searching for a vein . . .
Dr Linni. We cannot explain this finding. But we also ex-pected a longer operative time in patients without preoperative t
further discussion. One would have expected DVM to reduce
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mVM. In the end, we were surprised about the result, but it is
onsistent with the findings of other authors.
Dr Manikyam Mutyala (Brooklyn, NY). I agree with you
egarding getting the duplex examination preoperatively. You
lso have to do it in the operating room, because after general
nesthesia the vein spasm will be gone, and the vein that was
eported as thrombophlebitic vein may not be thrombophle-
itic. And sometimes if you have no choice of other conduit,
ou have to explore and see whether the vein is actually good or
ot. If needed, you can actually do angioscope and see inside
lso and have extra information.
Dr Linni. You are right, but in the preoperative setting you do
ot usually have the problem of venous spasm. So DVM at the day
efore surgery with a relaxed patient should usually detect a
hrombophlebitic great saphenous vein.INVITED COMMENTARYJoseph L. Mills, MD, Tucson, Ariz
The authors should be complimented for their provocative
research. Their article raises several points worthy of emphasis,
although I am skeptical of its final conclusions. In the endovascular
era, it is worth emphasizing that the following truths remain
self-evident: leg bypass still plays an important role in lower ex-
tremity revascularization, especially for patients on the more severe
end of the peripheral artery disease spectrum; best results are
obtained with vein grafts; and identifying the best available vein
conduit is important because it is the component of lower extrem-
ity bypass that is most critical to early and long-term success.
As with much of our infrainguinal revascularization database,
high-level evidence is sadly deficient. To their credit, the authors
conducted a single-institution, prospective, randomized study of
103 patients undergoing first-time, infrainguinal bypass with ipsi-
lateral great saphenous vein (GSV). Enrolled patients were ran-
domized to duplex vein mapping (DVM) with skin marking (n 
51) vs unmapped and unmarked (n  52) groups.
The authors detected no differences in mean operative time,
incision length, bypass length, minor wound or infection compli-
cations, initial hospital length of stay, and graft patency. However,
they reported a 10-fold reduction in major surgical site infections
(SSIs; ie, those requiring intravenous antibiotics or surgical de-
bridement, or both) and a five-fold reduction in the readmission
rate. These would be landmark findings if they could be replicated
by larger, multicenter trials.
Several of the reported findings seem peculiar and warrantperative time and perhaps incision length. In addition, there were
o instances of inadequate vein in theDVMgroup, and no changes
n intraoperative planning resulted from DVM. In contrast, six
atients in the no-DVM group had inadequate vein or vein seg-
ents requiring changes in intraoperative planning, use of alterna-
ive conduits, and presumably, vein splicing. These six patients
ccounted for most of the major SSI complications. One could
rgue that poor vein conduit increased the complication rate rather
han lack of DVM, and for uncertain reasons, all of the patients
ith poor conduit were randomized to the no-DVM group.
I certainly support preoperative vein mapping, especially in
atients who have had previous operations using GSV. When
erforming an operation where conduit quality is the major deter-
inant of success, it would seemworthwhile to identify and use the
est available conduit before proceeding. Identifying unusable
egments (sclerotic and occluded segments, prohibitively small
egments) and avoiding their needless exposure seem prudent.
arking the course of the vein on the skin also will likely help avoid
ndermining and the creation of skin flaps during vein harvest
hould reduce wound complications. It seems unlikely, however,
hat DVM will reduce the major SSI complication rate by 10-fold.
n fact, it is more likely that poor vein conduit and altering the
perative plan increase the frequency of SSI. Nonetheless, there are
ufficient data in this provocative report to encourage more wide-
pread use of DVM as an adjunct to leg bypass, but I would doubt
arger studies will be able to replicate the dramatic reduction in
ajor SSI and hospital readmission rates identified in this study.
